{"a":[{"_":"Why biotech revenue projections ‘won’t look as sunny’ once Trump tax bill hits Medicaid enrollment","$":{"href":"/biotech/unseen-impact-how-one-big-beautiful-bill-act-could-hamper-drug-development","hreflang":"en"}}]}

Summary

Trump administration tax and spend legislation could reduce Medicaid insurance coverage, potentially hampering biotech funding and clinical trial patient recruitment. The analysis discusses indirect negative impacts of policy changes on drug development across the sector.